By Michael Goldberg MD, PhD | Project Leader
Hello and welcome to another update from the Center for Allergy at the Shamir Medical Center! It looks like we are on a roll with hazelnut allergy, the subject of our last update, so I will continue where we left off on that topic.
Back in September, I mentioned that we were in the process of preparing two research papers about hazelnut allergy. I am now pleased to report that our paper about hazelnut oral immunotherapy has been accepted for publication by the Journal of Allergy and Clinical Immunology-In Practice. As a reminder, oral immunotherapy (OIT) is an emerging treatment modality for food allergies, in which patients ingest allergenic food at doses lower than their reaction threshold. As time goes on with this treatment, the reaction threshold increases (ie, patients are able to safely consume higher doses of food) until patients reach a point of being able to eat the allergenic food without restriction. Out of 30 hazelnut allergic patients in our study, 29 were successfully desensitized to hazelnut by OIT. Blood tests on these patients also showed that hazelnut-specific IgE antibodies decreased in these patients, which is notable since these antibodies are a main driver of allegy. In summary, we can now confirm that hazelnut allergy is on the list of allergies that can be safely and successfully treated by OIT.
The second paper concerns accurate diagnosis of hazelnut allergy. Diagnosing food allergies, and treenut allergies in particular is complicated. Positive test results from skin prick or IgE antibody testing don't always indicate true allergy. Sometimes patients are just sensitized to a particular food, but are still able to consume it. This occurs frequently in those with allergies to other, related foods. Thus, allergy testing procedures often require utilization of several different tests to provide accurate results. While we have previously published several papers detailing testing procedures for walnut and cashew allergies, it appears that hazelnut allergy diagnosis requires a different approach. Our paper on the topic is still in preparation, so while the specific details will be described later, the overall conclusion is that there is not a "one size fits all" approach to diagnosing hazelnut allergy. Allergic patients can react to various proteins of their allergenic foods, and our research indicates that patient history and background can help to determine which hazelnut proteins would be best to test in different patients. Notably, given the number of patients with various food allergies and different medical backgrounds that we regularly see at our center, we are looking to investigate this personalized testing approach for other food allergies, improving on accepted allergic testing schemes. This expanded investigation with the opportunity to improve food allergy diagnosis, will also require increased resources. We are grateful for assistance that our supporters have provided us throughout the years, and we turn to you now as well in support of this project, which has potential to upgrade allergy diagnostic performance in the future.
Looking forward to sharing more with you soon!
By Michael Goldberg MD, PhD | Project Leader
By Michael Goldberg MD, PhD | Project Leader
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser